Amanote Research
Register
Sign In
CD133 Regulates PI3K/AKT Signaling in Glioma Stem Cells
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2013-081
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
April 18, 2013
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Activation of PI3K/Akt Pathway by CD133-p85 Interaction Promotes Tumorigenic Capacity of Glioma Stem Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Docetaxel Promotes Cell Apoptosis and Decreases SOX2 Expression in CD133‑expressing Hepatocellular Carcinoma Stem Cells by Suppressing the PI3K/AKT Signaling Pathway
Oncology Reports
Medicine
Cancer Research
Oncology
Celecoxib Regulates Apoptosis and Autophagy via the PI3K/Akt Signaling Pathway in SGC-7901 Gastric Cancer Cells
International Journal of Molecular Medicine
Medicine
Genetics
McL1 Gene Silencing Promotes Senescence and Apoptosis of Glioma Cells via Inhibition of the PI3K/Akt Signaling Pathway
IUBMB Life
Biochemistry
Genetics
Clinical Biochemistry
Cell Biology
Molecular Biology
Flufenamic Acid Inhibits Adipogenic Differentiation of Mesenchymal Stem Cells by Antagonizing the PI3K/AKT Signaling Pathway
Stem Cells International
Cell Biology
Molecular Biology
FABP5 Regulates the Proliferation of Clear Cell Renal Cell Carcinoma Cells via the PI3K/AKT Signaling Pathway
International Journal of Oncology
Cancer Research
Oncology
Hyperthermia Sensitizes Glioma Stem Cells to Radiation by Inhibiting AKT
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
FoxM1 and WNT/ -Catenin Signaling in Glioma Stem Cells
Cancer Research
Cancer Research
Oncology
FOXP1 Regulation via the PI3K/Akt/p70S6K Signaling Pathway in Breast Cancer Cells
Oncology Letters
Cancer Research
Oncology